DOSSIER · 13F Holders · Q3 2026
NEUROSENSE THERAPEUTICS LTD
4 institutions still hold NEUROSENSE THERAPEUTICS LTD as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP M74240116·4 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q3 2026
4 institutions reported NEUROSENSE THERAPEUTICS LTD in Q3 2026. Empery Asset Management, LP leads at 61.1% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.